
Skyclarys Coupons & Savings Card – Discount Prices from $34093.07
My prescription
Edit
50MG, Skyclarys (90 Capsules)
Select pharmacy

Albertsons
$34093.07
COUPON PRICE
Walmart
$34264.75
COUPON PRICE
Walgreens
$34275.74
COUPON PRICESkyclarys savings card
Show this card to your pharmacist
Albertsons
$34093.07
BIN
ID
PCN
GRP
019876
LHC11CAE9A
CHIPPO
LHX
Powered by
Price history for Skyclarys
90 Capsules, 50MG
Average retail price for Skyclarys
Average SaveHealth price for Skyclarys
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Skyclarys dosage forms
Dosage Quantity Price from Per unit 50MG 90 Capsules $34093.07 $378.81
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 50MG | 90 Capsules | $34093.07 | $378.81 |
What is Skyclarys used for?
Skyclarys is used for the treatment of Friedreich's ataxia, a rare genetic disorder that affects the nervous system and movement.
How much does Skyclarys cost?
The cost of Skyclarys can vary depending on factors such as insurance coverage, pharmacy pricing, and location. It is recommended to contact a local pharmacy or healthcare provider for the most accurate and up-to-date pricing information. Additionally, patients may inquire about patient assistance programs or insurance coverage options that could help reduce the cost.
Is Skyclarys a specialty drug?
Yes, Skyclarys is considered a specialty drug. Specialty drugs are typically used to treat complex or rare conditions and often require special handling, administration, or monitoring.
How effective is Skyclarys?
Skyclarys (omaveloxolone) is a medication approved for the treatment of Friedreich's ataxia, a rare genetic disorder. Clinical trials have shown that Skyclarys can improve neurological function in patients with this condition. The effectiveness can vary among individuals, and it is important for patients to discuss with their healthcare provider to understand how it may benefit their specific situation.
Is Skyclarys approved by the FDA?
Yes, Skyclarys (omaveloxolone) is approved by the FDA. It was approved in February 2023 for the treatment of Friedreich's ataxia in adults and adolescents aged 16 years and older.
